These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7340007)

  • 21. Gastrointestinal absorption and organ distribution of oral cadmium chloride and cadmium-metallothionein in mice.
    Cherian MG; Goyer RA; Valberg LS
    J Toxicol Environ Health; 1978; 4(5-6):861-8. PubMed ID: 731733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary metallothionein and tissue metal levels of rats injected with cadmium, mercury, lead, copper or zinc.
    Lee YH; Shaikh ZA; Tohyama C
    Toxicology; 1983; 27(3-4):337-45. PubMed ID: 6623481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of chelating agents on toxicity and distribution of cadmium among proteins of mouse liver and kidney following oral or subcutaneous exposure.
    Engström B
    Acta Pharmacol Toxicol (Copenh); 1981 Feb; 48(2):108-17. PubMed ID: 7257822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrepancy between the nephrotoxic potencies of cadmium-metallothionein and cadmium chloride and the renal concentration of cadmium in the proximal convoluted tubules.
    Dorian C; Gattone VH; Klaassen CD
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):161-8. PubMed ID: 7839364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term turnover of cadmium metallothionein in liver and kidney following a single low dose of cadmium in rats.
    Ridlington JW; Winge DR; Fowler BA
    Biochim Biophys Acta; 1981 Mar; 673(2):177-83. PubMed ID: 7213819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relationship between plasma anti-metallothionein antibody and renal dysfunction in cadmium exposed workers].
    Chen L; Jin TY; Chang XL; Lei LJ; Zhou YF
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):7-11. PubMed ID: 16600085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of increase in urinary metallothionein of rats repeatedly exposed to cadmium.
    Sugihira N; Tohyama C; Murakami M; Saito H
    Toxicology; 1986 Oct; 41(1):1-9. PubMed ID: 3750333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of N-benzyl-D-glucamine dithiocarbamate on distribution and excretion of cadmium in rats.
    Kojima S; Kiyozumi M; Honda T; Kaminaka K; Oda Y; Senba Y
    Toxicology; 1987 Jul; 45(1):93-102. PubMed ID: 3603577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biosynthesis of metallothionein rat liver and kidney after administration of cadmium.
    Shaikh ZA; Smith JC
    Chem Biol Interact; 1976 Dec; 15(4):327-36. PubMed ID: 1009631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of zinc and copper administration on metal disposition in rats with cadmium-metallothionein-induced nephrotoxicity.
    Liu X; Jin T; Nordberg GF; Sjöström M; Zhou Y
    Toxicol Appl Pharmacol; 1994 May; 126(1):84-90. PubMed ID: 8184437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shifts in the dose-effect relationship for the nephropathy induced by cadmium-metallothionein in rats after a reduction in renal mass.
    Zalups RK; Gelein RM; Cherian MG
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1256-66. PubMed ID: 1527728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metallothionein and occupational exposure to cadmium.
    Falck FY; Fine LJ; Smith RG; Garvey J; Schork A; England B; McClatchey KD; Linton J
    Br J Ind Med; 1983 Aug; 40(3):305-13. PubMed ID: 6347245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies of cadmium uptake and metabolism by the kidney.
    Suzuki KT
    Environ Health Perspect; 1984 Mar; 54():21-30. PubMed ID: 6734557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal accumulation of cadmium and nephropathy following long-term administration of cadmium-metallothionein.
    Min KS; Onosaka S; Tanaka K
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):102-9. PubMed ID: 8917681
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China.
    Chen L; Jin T; Huang B; Nordberg G; Nordberg M
    Toxicol Appl Pharmacol; 2006 Aug; 215(1):93-9. PubMed ID: 16510161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cadmium disposition and metallothionein induction in mice: strain-, sex-, age- and dose-dependent differences.
    Shaikh ZA; Jordan SA; Tewari PC
    Toxicology; 1993 Jun; 80(1):51-70. PubMed ID: 8322372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephrotoxicity in rats following liver transplantation from cadmium-exposed rats.
    Chan HM; Zhu LF; Zhong R; Grant D; Goyer RA; Cherian MG
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):89-96. PubMed ID: 8236266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism of orally administered cadmium-metallothionein in mice.
    Cherian MG
    Environ Health Perspect; 1979 Feb; 28():127-30. PubMed ID: 488030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nephrotoxicities of aluminium and/or cadmium-metallothionein in rats: creatinine excretion and metabolism of selected essential metals.
    Liu JX; Nordberg GF
    Pharmacol Toxicol; 1995 Aug; 77(2):155-60. PubMed ID: 8584507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of metallothionein on the liver and kidney of rats by subchronic lead and cadmium in combination.
    Dai S; Yin Z; Yuan G; Lu H; Jia R; Xu J; Song X; Li L; Shu Y; Liang X; He C; Lv C; Zhang W
    Environ Toxicol Pharmacol; 2013 Nov; 36(3):1207-16. PubMed ID: 24184865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.